nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Benefit–Risk Profile of Sphingosine-1-Phosphate Receptor Modulators in Relapsing and Secondary Progressive Multiple Sclerosis
|
Comi, Giancarlo |
|
2017 |
77 |
16 |
p. 1755-1768 |
artikel |
2 |
Dual Antiplatelet Therapy Duration: Reconciling the Inconsistencies
|
Costa, Francesco |
|
2017 |
77 |
16 |
p. 1733-1754 |
artikel |
3 |
Elsulfavirine: First Global Approval
|
Al-Salama, Zaina T. |
|
|
77 |
16 |
p. 1811-1816 |
artikel |
4 |
Elsulfavirine: First Global Approval
|
Al-Salama, Zaina T. |
|
2017 |
77 |
16 |
p. 1811-1816 |
artikel |
5 |
Erratum to: Durvalumab: First Global Approval
|
Syed, Yahiya Y. |
|
2017 |
77 |
16 |
p. 1817 |
artikel |
6 |
Glecaprevir/Pibrentasvir: First Global Approval
|
Lamb, Yvette N. |
|
2017 |
77 |
16 |
p. 1797-1804 |
artikel |
7 |
Overlapping Effects of New Monoclonal Antibodies for Severe Asthma
|
Domingo, Christian |
|
2017 |
77 |
16 |
p. 1769-1787 |
artikel |
8 |
Pemafibrate: First Global Approval
|
Blair, Hannah A. |
|
2017 |
77 |
16 |
p. 1805-1810 |
artikel |
9 |
Pharmacological Management of Chronic Rhinosinusitis: Current and Evolving Treatments
|
Beswick, Daniel M. |
|
2017 |
77 |
16 |
p. 1713-1721 |
artikel |
10 |
Pharmacological Management of Gestational Diabetes Mellitus
|
Mukerji, Geetha |
|
2017 |
77 |
16 |
p. 1723-1732 |
artikel |
11 |
Raltegravir Once-Daily Tablet: A Review in HIV-1 Infection
|
Deeks, Emma D. |
|
|
77 |
16 |
p. 1789-1795 |
artikel |
12 |
Raltegravir Once-Daily Tablet: A Review in HIV-1 Infection
|
Deeks, Emma D. |
|
2017 |
77 |
16 |
p. 1789-1795 |
artikel |